Evidence map›Paper›PMID 40916930›Full record

ArticleJournal of clinical psychopharmacology

Gender Differences in Psychotropic Medication Use: A Naturalistic Study Among Psychiatric Outpatients in Secondary Care.

Edith J Liemburg, Klaas J Wardenaar, Sanne Krol, Maaike M van Veen, Bennard Doornbos, Arne Risselada, Danielle C Cath

Abstract read
In one paragraph

Article in Journal of clinical psychopharmacology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Edith J LiemburgGGZ Friesland, Department of Research, Leeuwarden.ORCID 0009-0005-7088-0730
Klaas J WardenaarDepartment of Child and Family Welfare, Faculty of Behavioural and Social Sciences, University of Groningen, Groningen.
Sanne KrolGGZ Drenthe Mental Health Services, Assen, The Netherlands.
Maaike M van VeenGGZ Drenthe Mental Health Services, Assen, The Netherlands.
Bennard DoornbosLentis Mental Health Organization, Lentis Research, Groningen.
Arne RisseladaDepartment of Clinical Pharmacy, Wilhelmina Hospital, Assen, The Netherlands.
Danielle C CathDepartment of Psychiatry, Rob Giel Research Center, University of Groningen, University Medical Center Groningen.

Funding

Espria Investeringsfonds GR 18 - 130 b
6 · The paper itself

Abstract

PURPOSE/

backgroundPrevious studies among psychiatric patients have shown differences between men and women in psychotropic medication prescription patterns. The factors underlying these differences are still poorly understood. This exploratory study aimed to investigate a range of clinical and demographic factors in their contributions to explaining these gender differences. METHODS/PROCEDURES: In 2476 outpatients with a mental disorder (mean age 46.1 year, 58.2% women) enrolled in pharmacotherapy monitoring program, regression analyses were used to investigate the associations of gender with use of any psychotropic (yes/no), use of each separate psychotropic type (yes/no), number (0 to 4) and dosage of each used psychotropic. Next, clinical and demographic effect modifiers and explanatory/confounding factors of these associations were identified. FINDINGS/

resultsFrequencies of general psychotropic use, antidepressant use, anxiolytic use, as well as polypharmacy were significantly higher in women than in men across all ages (premenopausal, perimenopausal, and postmenopausal), with equal dosing of psychotropics, except for higher doses of mood stabilizers in men. Longer illness duration and having a partner were effect modifiers of the gender effect, while higher frequencies of an affective/anxiety diagnosis, higher somatic complaints and symptomatic distress, more previous mental health service (MHS) visits and no current occupation were explanatory factors. IMPLICATIONS/

conclusionsPsychotropic use and psychotropic polypharmacy were more common in women than in men. Women on psychotropic medications were more often diagnosed with affective/anxiety diagnoses, experienced more symptomatic distress and somatic complaints, and visited more healthcare services than men, reaffirming findings from previous studies. Future longitudinal studies should investigate in further detail whether these outcomes are cause or consequence of gender differences in psychotropic medication use.

Indexed as

Mental DisordersPsychotropic DrugsSecondary Health CareAdultAgedAnti-Anxiety AgentsAntidepressive AgentsFemaleHumansMaleMiddle AgedOutpatientsPolypharmacySex FactorsYoung AdultAnti-Anxiety AgentsAntidepressive AgentsPsychotropic Drugsgenderpolypharmacypsychiatric disorderpsychotropic usesex

Identifiers

PMID40916930
PMCPMC12713693

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.